NCT06596135Phase 3Completed

Open-Label Extension Study of Setmelanotide

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-06-24Actual
Enrollment · participants28Actual
Source updated2026-07-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 30 participants (planned). After: 28 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 30 Oct 2027. After: 24 Jun 2026.

Recruitment status changed

Before: Enrolling by invitation. After: Completed.

Check registry source